AI-generated summary
The authors report a randomized controlled trial in which 14 chronic kidney failure patients received 24 sessions of photobiomodulation on the lower limbs during hemodialysis, compared with 14 controls receiving dialysis alone. The intervention group showed greater functional capacity on the six-minute walk test and improved lower limb strength on the sit-and-stand test. Other outcomes showed no significant between-group difference.
- Who or what was studied
- Adults with chronic kidney failure receiving hemodialysis
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract reports a small sample of 14 patients per group and does not describe the control arm's blinding or long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Power
- 200 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Photobiomodulation therapy, Effect size, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.